tiprankstipranks
Advertisement
Advertisement

ACIU Stock Latest News

AC Immune presents new Phase 1 data on uptake of ACI-19626
The FlyAC Immune presents new Phase 1 data on uptake of ACI-19626
1d ago
ACIU
AC Immune Sets June AGM and Reshapes Leadership as Long-Serving CEO Retires
PremiumCompany Announcements
AC Immune Sets June AGM and Reshapes Leadership as Long-Serving CEO Retires
8d ago
6K
ACIU
AC Immune CEO and Co-Founder Andrea Pfeifer to Retire at June 11 AGM; Board Chair Martin Zügel Named Interim Chief
PremiumCompany Announcements
AC Immune CEO and Co-Founder Andrea Pfeifer to Retire at June 11 AGM; Board Chair Martin Zügel Named Interim Chief
11d ago
6K
ACIU
AC Immune reports Q1 EPS (15c), consensus (14c)
PremiumThe Fly
AC Immune reports Q1 EPS (15c), consensus (14c)
23d ago
ACIU
AC Immune Triggers $12 Million Takeda Milestone as Final ABATE Cohort Starts in Alzheimer’s Trial
PremiumCompany Announcements
AC Immune Triggers $12 Million Takeda Milestone as Final ABATE Cohort Starts in Alzheimer’s Trial
23d ago
6K
ACIU
AC Immune Posts Q1 2026 Update, Extends Cash Runway and Advances Neurodegeneration Pipeline
PremiumCompany AnnouncementsAC Immune Posts Q1 2026 Update, Extends Cash Runway and Advances Neurodegeneration Pipeline
23d ago
6K
ACIU
Is ACIU a Buy, Before Earnings?
Premium
Pre-Earnings
Is ACIU a Buy, Before Earnings?
1M ago
ACIU
Leerink calls AC Immune- Eli Lilly Tau amendment ‘great news’
Premium
The Fly
Leerink calls AC Immune- Eli Lilly Tau amendment ‘great news’
2M ago
LLY
ACIU
AC Immune Secures Amended Tau Drug Collaboration with Lilly, Adds CHF 10 Million Upfront
PremiumCompany Announcements
AC Immune Secures Amended Tau Drug Collaboration with Lilly, Adds CHF 10 Million Upfront
2M ago
6K
ACIU
AC Immune announces amendment to Eli Lilly license pact, to receive CHF 10M
PremiumThe Fly
AC Immune announces amendment to Eli Lilly license pact, to receive CHF 10M
2M ago
LLY
ACIU
AC Immune’s PET tracer shows efficacy detecting brain pathologies
PremiumThe Fly
AC Immune’s PET tracer shows efficacy detecting brain pathologies
2M ago
ACIU
AC Immune: Advancing Neurology Pipeline and Imminent Alzheimer’s Vaccine Data Support Buy Rating
PremiumRatings
AC Immune: Advancing Neurology Pipeline and Imminent Alzheimer’s Vaccine Data Support Buy Rating
2M ago
ACIU
AC Immune: Advancing Alzheimer’s and Parkinson’s Pipeline Catalysts Underpin Buy Rating and Favorable Risk‑Reward
PremiumRatingsAC Immune: Advancing Alzheimer’s and Parkinson’s Pipeline Catalysts Underpin Buy Rating and Favorable Risk‑Reward
2M ago
ACIU
AC Immune Posts 2025 Results, Sharpens Pipeline Focus and Extends Cash Runway to 2027
Premium
Company Announcements
AC Immune Posts 2025 Results, Sharpens Pipeline Focus and Extends Cash Runway to 2027
2M ago
6K
ACIU
AC Immune reports FY25 EPS (CHF 0.70) vs (CHF 0.51) last year
Premium
The Fly
AC Immune reports FY25 EPS (CHF 0.70) vs (CHF 0.51) last year
2M ago
ACIU
ACIU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ACIU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ACIU
AC Immune Doses First Participant in Phase 1 Trial of NLRP3 Inhibitor ACI-19764
PremiumCompany Announcements
AC Immune Doses First Participant in Phase 1 Trial of NLRP3 Inhibitor ACI-19764
3M ago
6K
ACIU
AC Immune initiates Phase 1 trial of NLRP3 inhibitor
PremiumThe Fly
AC Immune initiates Phase 1 trial of NLRP3 inhibitor
3M ago
ACIU
AC Immune Says Janssen Pauses Enrollment in Alzheimer’s Trial but Confirms Cash Runway to Q3 2027
PremiumCompany Announcements
AC Immune Says Janssen Pauses Enrollment in Alzheimer’s Trial but Confirms Cash Runway to Q3 2027
3M ago
6K
ACIU
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results
PremiumRatingsPromising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results
5M ago
ACIU
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results
Premium
The Fly
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results
5M ago
ACIU
AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy
Premium
Company Announcements
AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy
5M ago
6K
ACIU

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >